Screener
Vir Biotechnology, Inc. VIR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other income | 6,792 | 7,629 | 13,557 | 26,227 |
| Income (loss) before provision for income taxes | 80,259 | (110,788) | (45,266) | (231,737) |
| Provision for income taxes | (179) | (170) | (349) | (186) |
| Net income (loss) | $80,080 | $(110,958) | $(45,615) | $(231,923) |
| Net income (loss) per share, basic | $0.48 | $(0.80) | $(0.29) | $(1.68) |
| Net income (loss) per share, diluted | $0.47 | $(0.80) | $(0.29) | $(1.68) |
| Weighted-average shares outstanding, basic | 167,719,015 | 138,447,469 | 157,613,578 | 137,960,888 |
| Weighted-average shares outstanding, diluted | 168,879,127 | 138,447,469 | 157,613,578 | 137,960,888 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s shares (diluted)?
- Vir Biotechnology, Inc. (VIR) reported shares (diluted) of 168.9M in Q2 2026.
- How has Vir Biotechnology, Inc.'s shares (diluted) changed year-over-year?
- Vir Biotechnology, Inc.'s shares (diluted) increased by 22.0% year-over-year, from 138.4M to 168.9M.
- What is the long-term trend for Vir Biotechnology, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s shares (diluted) has grown at a 1.1% compound annual growth rate (CAGR), from 528.8M to 553.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Vir Biotechnology, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude